Shares of Vor Bio are up 120% in pre-market trade on Thursday. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do ...

Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions By Angus Liu Jun 26, 2025 10:55am Vor Biopharma RemeGen Autoimmune Diseases Licensing deals ...

Vor is paying RemeGene $45 million upfront along with $80 million in warrants to purchase common stock in exchange for the drug, called telitacicept. Telitacicept is in Phase 3 testing for generalized ...

GlobalAir.com receives its data from NOAA, NWS, FAA and NACO, and Weather Underground. We strive to maintain current and accurate data. However, GlobalAir.com cannot guarantee the data received from ...

"Calling this a crisis, saying it's real. That's a shift I think," says demographer Anna Rotkirch, who has researched fertility intentions in Europe and advises the Finnish government on ...

I've Lived in Virginia for 23+ Years—and This Small Town Is One of My Favorite Hidden Gems An insider's guide to Bedford, Virginia, home to scenic hiking trails, moving historical landmarks, and ...

Launch LYH names 5 new business winners for third and final year of the program. (Credit: Downtown Lynchburg Association) "I am so excited, and I can't wait to get started," Forth said.

Big, fast-growing companies are delivering most of the economy’s productivity growth and higher wages for workers, according to a McKinsey study that challenges government moves to crack down on ...

David Evans, managing partner at Watermark, also advocated for targets. “We need to do something, because what we’re doing is not working. Targets are one of the things we should look at ...